Safety and efficacy of inactivated COVID-19 vaccines in women vaccinated during the first trimester of pregnancy

[1]  Mufakhara Fatimah,et al.  Safety and efficacy of Sinopharm vaccine (BBIBP-CorV) in elderly population of Faisalabad district of Pakistan , 2022, Postgraduate medical journal.

[2]  N. Pearce,et al.  CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study , 2022, BMC Medicine.

[3]  G. Screaton,et al.  Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study , 2022, The Lancet.

[4]  A. N. Barbosa,et al.  Vertical transmission of maternal COVID-19 antibodies after CoronaVac vaccine: A case report , 2021, Revista da Sociedade Brasileira de Medicina Tropical.

[5]  R. W. Yung,et al.  Serological response to mRNA and inactivated COVID-19 vaccine in healthcare workers in Hong Kong: decline in antibodies 12 weeks after two doses. , 2021, Hong Kong medical journal = Xianggang yi xue za zhi.

[6]  A. Soysal,et al.  Cord blood antibody following maternal SARS-CoV-2 inactive vaccine (CoronaVac) administration during the pregnancy , 2021, Human vaccines & immunotherapeutics.

[7]  E. Undurraga,et al.  Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile , 2021, The New England journal of medicine.

[8]  A. Yılmaz,et al.  Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey , 2021, The Lancet.

[9]  R. W. Yung,et al.  Serological response to mRNA and inactivated COVID-19 vaccine in healthcare workers in Hong Kong: preliminary results. , 2021, Hong Kong medical journal = Xianggang yi xue za zhi.

[10]  Changgui Li,et al.  Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial , 2021, The Lancet Infectious Diseases.

[11]  T. Waśniewski,et al.  Evaluation of SARS-CoV-2 Spike Protein Antibody Titers in Cord Blood after COVID-19 Vaccination during Pregnancy in Polish Healthcare Workers: Preliminary Results , 2021, Vaccines.

[12]  M. Hassany,et al.  Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial. , 2021, JAMA.

[13]  Dilek Şahin,et al.  COVID‐19 vaccine acceptance in pregnant women , 2021, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[14]  J. Goldstein,et al.  Cord blood antibodies following maternal coronavirus disease 2019 vaccination during pregnancy , 2021, American Journal of Obstetrics and Gynecology.

[15]  S. Hayakawa,et al.  Anti‐SARS‐CoV‐2 vaccination strategy for pregnant women in Japan , 2021, The journal of obstetrics and gynaecology research.

[16]  Cresta W. Jones,et al.  Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies in Neonatal Cord Blood After Vaccination in Pregnancy , 2021, Obstetrics and gynecology.

[17]  Jeffrey S. Morris,et al.  Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios. , 2021, JAMA pediatrics.

[18]  K. Chu,et al.  Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial , 2020, The Lancet Infectious Diseases.

[19]  Wenling Wang,et al.  Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial , 2020, The Lancet Infectious Diseases.

[20]  J. Hutcheon,et al.  Maternal outcome of pregnant women admitted to intensive care units for coronavirus disease 2019 , 2020, American Journal of Obstetrics and Gynecology.

[21]  N. Shah,et al.  Is the Host Viral Response and the Immunogenicity of Vaccines Altered in Pregnancy? , 2020, Antibodies.

[22]  A. Dyer,et al.  International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy , 2010, Diabetes Care.

[23]  T. Shima,et al.  REVIEW ARTICLE: Th1/Th2/Th17 and Regulatory T‐Cell Paradigm in Pregnancy , 2010, American journal of reproductive immunology.

[24]  Ken P Kleinman,et al.  A nearly continuous measure of birth weight for gestational age using a United States national reference , 2003, BMC pediatrics.

[25]  A. Gilman‐Sachs,et al.  Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. , 2003, Human reproduction.